期刊文献+

2型糖尿病与非糖尿病患者非酒精性脂肪肝发病情况的临床分析 被引量:4

Clinical analysis on incidence of NAFL in patients with and without diabetes
下载PDF
导出
摘要 目的研究2型糖尿病(T2MD)患者与非糖尿病患者非酒精性脂肪肝发病情况和特点。方法选择T2MD非酒精性脂肪肝患者50例(A组),非糖尿病非酒精性脂肪肝患者50例(B组)和健康人群50例(C组),观察分析三组人员的相关临床检测指标。结果非酒精性脂肪肝患者的体质量指数(BMI)、空腹血糖(FBG)、总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)均高于健康组(P<0.05);A组患者的FBG、TC、TG、LDL-C指标方面均显著高于B组,HDL-C、胰岛素敏感指数(HOMA-ISI)指标均明显低于B组(P<0.05)。结论糖尿病会加剧非酒精性脂肪肝病情,为了能有效预防和控制非酒精性脂肪肝,应改变饮食结构、控制体质量,加强锻炼,并做到定期体检,做到及早发现,及时诊断治疗。 Objective To study the incidence and characteristics of nonalcoholic fatty liver (NAFL) in the patients with and without type II diabetes mellitus (T2DM). Methods Subjects consisted of 50 NAFL patients with T2DM (Group A), 50 NAFL patients without T2DM ( Group B) and 50 healthy volunteers ( Group C). Related clinical laboratory parameters were tested. Results The parameters such as body mass index (BMI), fasting blood glucose (FBG), total cholesterol (TC), triglyceride (TG) ,low density lipoprotein-eholesterol(LDL-C) ,FINS (fasting insulin) and homeostasis model assessment of insulin resistance (HOMA-IR) were significantly higher in the NAFL patients than in the healthy volunteers (P 〈 0.05). FBG, TC, TG and LDL-C were significantly higher and HDL-C and HOMA-ISI were significantly lower in Group A than in Group B ( P 〈 0.05 ). Conclusion Diabetes can exacerbate NAFL. In order to effectively prevent and control NAFL, people should change in diet, control weight, do exercises and undergo regular medical examination.
作者 罗红
出处 《临床军医杂志》 CAS 2013年第4期345-346,共2页 Clinical Journal of Medical Officers
关键词 糖尿病 非糖尿病 非酒精性脂肪肝 diabetes non-diabetes nonalcoholic fatty liver
  • 相关文献

参考文献6

二级参考文献29

共引文献33

同被引文献48

  • 1中华医学会精神科分会,中国精神障碍分类与诊断标准(第3版)[M].山东:山东科学技术出版社,2001:31-36.
  • 2Mitchell AJ,Vancampfort D,Sweers K,et al.Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis[J].Schizophr Bull,2013,39(2):306-318.
  • 3Dixon L,Perkins D,Calmes C.Guideline watch(September2009):Practice guideline for the treatment of patients with schizophrenia[M].Washington:American Psychiatric Association,2009:1-10.
  • 4Hasan A,Falkai P,Wobrock T,et al.World Federation of Societies of Biological Psychiatry(WFSBP)guidelines for biological treatment of schizophrenia,part 2:update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects[J].World J Biol Psychiatry,2013,14(1):2-44.
  • 5Coccurello R,Brina D,Caprioli A,et al.30 days of continuous olanzapine infusion determines energy imbalance,glucose intolerance,insulin resistance,and dyslipidemia in mice[J].J Clin Psychopharmacol,2009,29(6):576-583.
  • 6Burghardt KJ,Ellingrod VL.Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy:is there a role for folate[J]?Mol Diagn Ther,2013,17(1):21-30.
  • 7Xia MF,Yan HM,He WY,et al.Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content:an improvement method[J].Obesity(Silver Spring),2012,20(2):444-452.
  • 8Musso G,Gambino R,Cassader M,et al.A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease[J].Hepatology,2010,52(1):79-104.
  • 9Hernaez R,Lazo M,Bonekamp S,et al.Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver:a meta-analysis[J].Hepatology,2011,54(3):1082-1090.
  • 10Minet-Ringuet J,Even PC,Valet P,et al.Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment[J].Mol Psychiatry,2007,12(6):562-571.

引证文献4

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部